Standard Chemical & Pharmaceutical Co Ltd (1720) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.057x

Based on the latest financial reports, Standard Chemical & Pharmaceutical Co Ltd (1720) has a cash flow conversion efficiency ratio of 0.057x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$510.55 Million ≈ $16.09 Million USD) by net assets (NT$9.02 Billion ≈ $284.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Standard Chemical & Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Standard Chemical & Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Standard Chemical & Pharmaceutical Co Lt carry for a breakdown of total debt and financial obligations.

Standard Chemical & Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Standard Chemical & Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
NICE Holdings Co. Ltd
KO:034310
0.130x
Jindal Poly Films Limited
NSE:JINDALPOLY
-0.022x
China Western Power Industrial Co Ltd
SHE:002630
0.012x
BOE Tech Group
SHE:200725
0.071x
Sumber Global Energy Tbk Pt
JK:SGER
0.029x
FocalTech Systems Co Ltd
TW:3545
0.063x
Orchid Pharma Limited
NSE:ORCHPHARMA
0.009x
Mo-Bruk SA
WAR:MBR
-0.056x

Annual Cash Flow Conversion Efficiency for Standard Chemical & Pharmaceutical Co Ltd (2002–2024)

The table below shows the annual cash flow conversion efficiency of Standard Chemical & Pharmaceutical Co Ltd from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Standard Chemical & Pharmaceutical Co Lt worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 NT$8.98 Billion
≈ $282.80 Million
NT$1.69 Billion
≈ $53.40 Million
0.189x +14.97%
2023-12-31 NT$8.14 Billion
≈ $256.37 Million
NT$1.34 Billion
≈ $42.11 Million
0.164x -0.53%
2022-12-31 NT$7.44 Billion
≈ $234.26 Million
NT$1.23 Billion
≈ $38.68 Million
0.165x +35.76%
2021-12-31 NT$6.80 Billion
≈ $214.23 Million
NT$827.03 Million
≈ $26.06 Million
0.122x -35.32%
2020-12-31 NT$4.91 Billion
≈ $154.56 Million
NT$922.58 Million
≈ $29.07 Million
0.188x +36.97%
2019-12-31 NT$4.65 Billion
≈ $146.39 Million
NT$637.94 Million
≈ $20.10 Million
0.137x +20.22%
2018-12-31 NT$4.25 Billion
≈ $133.78 Million
NT$484.94 Million
≈ $15.28 Million
0.114x -32.29%
2017-12-31 NT$4.20 Billion
≈ $132.39 Million
NT$708.74 Million
≈ $22.33 Million
0.169x +131.78%
2016-12-31 NT$4.20 Billion
≈ $132.22 Million
NT$305.38 Million
≈ $9.62 Million
0.073x -56.54%
2015-12-31 NT$3.89 Billion
≈ $122.46 Million
NT$650.87 Million
≈ $20.51 Million
0.167x +3.69%
2014-12-31 NT$3.61 Billion
≈ $113.60 Million
NT$582.30 Million
≈ $18.35 Million
0.161x +35.41%
2013-12-31 NT$3.58 Billion
≈ $112.87 Million
NT$427.26 Million
≈ $13.46 Million
0.119x -1.97%
2012-12-31 NT$3.31 Billion
≈ $104.17 Million
NT$402.25 Million
≈ $12.67 Million
0.122x -6.33%
2011-12-31 NT$3.12 Billion
≈ $98.36 Million
NT$405.49 Million
≈ $12.78 Million
0.130x +38.92%
2010-12-31 NT$2.91 Billion
≈ $91.81 Million
NT$272.47 Million
≈ $8.58 Million
0.094x -58.59%
2009-12-31 NT$2.81 Billion
≈ $88.50 Million
NT$634.23 Million
≈ $19.98 Million
0.226x -18.22%
2008-12-31 NT$2.60 Billion
≈ $82.07 Million
NT$719.17 Million
≈ $22.66 Million
0.276x +119.99%
2007-12-31 NT$2.58 Billion
≈ $81.23 Million
NT$323.60 Million
≈ $10.20 Million
0.126x -9.88%
2006-12-31 NT$2.58 Billion
≈ $81.17 Million
NT$358.75 Million
≈ $11.30 Million
0.139x -9.29%
2005-12-31 NT$2.42 Billion
≈ $76.09 Million
NT$370.77 Million
≈ $11.68 Million
0.154x -17.69%
2004-12-31 NT$1.80 Billion
≈ $56.67 Million
NT$335.45 Million
≈ $10.57 Million
0.187x +13.25%
2003-12-31 NT$1.66 Billion
≈ $52.21 Million
NT$272.89 Million
≈ $8.60 Million
0.165x +75.71%
2002-12-31 NT$1.58 Billion
≈ $49.67 Million
NT$147.75 Million
≈ $4.66 Million
0.094x --

About Standard Chemical & Pharmaceutical Co Ltd

TW:1720 Taiwan Drug Manufacturers - Specialty & Generic
Market Cap
$343.42 Million
NT$10.90 Billion TWD
Market Cap Rank
#14397 Global
#578 in Taiwan
Share Price
NT$61.00
Change (1 day)
-0.65%
52-Week Range
NT$54.10 - NT$65.60
All Time High
NT$77.40
About

Standard Chemical & Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese and western medicine, cosmetics, beverage, normal instruments, and medical instruments. It also sells various medical supplements, as well as preventive medicine; and imports and exports various medical products, med… Read more